A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system ...

About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...

When the news arrived in August that what could be the first personalized mRNA cancer vaccine had succeeded in a late-stage ...

A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a ...

Moderna launched its coronavirus vaccine in early pandemic days and saw revenue and stock performance skyrocket. As demand ...

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according ...